Golden Meditech to Sell its equity Interest in China Cord Blood Corporation for Cash Consideration of RMB5.764 Billion
HONG KONG, Dec. 30, 2016 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise inChina, announces that it entered into a sale ...
China Cord Blood Corporation Announces Results of 2016 Annual General Meeting
HONG KONG, Dec. 9, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2016 Annual Gener...
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2017
HONG KONG, Nov. 18, 2016 /PRNewswire/ -- * 2Q17 Added 18,037 New Subscribers * 2Q17 Revenue Up 7.4% YOY to RMB184.1 Million ($27.6 Million) * 2Q17 Operating Income Up 4.3% YOY to RMB54.7 Million ($8.2 Million) * Conference Call to be Held on November 18, 2016 at 8:00 a.m. ET China Cord Bl...
China Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2017 Financial Results
HONG KONG, Nov. 10, 2016 /PRNewswire/ -- -- Earnings Call Scheduled for 8:00 a.m. ET on November 18, 2016 China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the second quarter and first half fiscal year 2017 onThursday, Novemb...
China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 9, 2016
HONG KONG, Sept. 23, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 201...
China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2017
HONG KONG, Aug. 23, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial ...
China Cord Blood Corporation to Report First Quarter of Fiscal 2017 Financial Results
HONG KONG, Aug. 16, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the first quarter of fiscal year 2017 onMonday, August 22, 2016, after market close. The Company will host a conference call at 8:00 a.m...
China Cord Blood Corporation Files Its Annual Report on Form 20-F
HONG KONG, July 29, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual R...
China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2016
HONG KONG, June 15, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financ...
China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2016 Financial Results
HONG KONG, June 7, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the fourth quarter and full year fiscal year 2016 onTuesday, June 14, 2016, after market close. The Company will host a conference call a...
April 5, 2016 Open Letter to the Special Committee of the Board of China Cord Blood Corp from Jayhawk Capital
NEW YORK, April 6, 2016 /PRNewswire/ -- The following is an open letter sent April 5, 2016 to the Board of Directors of China Cord Blood Corp (NYSE: CO) from Jayhawk Capital. It is clear that the Board should accept a privatization offer only if ALL shareholders will receive the same $15+ per sh...
China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2016
HONG KONG, March 1, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial...
China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2016 Financial Results
HONG KONG, Feb. 22, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the third quarter and first nine months of fiscal year 2016 onMonday, February 29, 2016, after market close. The Company will host a c...
Golden Meditech Enters into Agreements with Nanjing Xinjiekou to Sell China Cord Blood Corporation
HONG KONG, Jan. 7, 2016 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 801, TWSE stock code: 910801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise inChina, announces that it entered into a conditio...
China Cord Blood Corporation Announces Results of 2015 Annual General Meeting
HONG KONG, Dec. 10, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2015 Annual Gene...
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2016
HONG KONG, Nov. 24, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financ...
China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2016 Financial Results
HONG KONG, Nov. 16, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the second quarter and first half of fiscal year 2016 onMonday, November 23, 2015, after market close. The Company will host a confere...
China Cord Blood Corporation Guangdong Subsidiary Has Been Accredited by American Association of Blood Banks
HONG KONG, Oct. 30, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company'sGuangdong subsidi...
China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 10, 2015
HONG KONG, Sept. 23, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 201...
September 9, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital
NEW YORK, Sept. 10, 2015 /PRNewswire/ -- The following is an open letter sent September 9, 2015 to the Board of Directors of China Cord Blood Corp (NYSE: CO) from Jayhawk Capital. We reiterate our conviction that the special committee of the independent directors of China Cord Blood Corp ("China...
